🧠 ✅ Instruct client to use sugarless gum or hard candy

🧠 Clozapine commonly causes anticholinergic side effects, including dry mouth (xerostomia).

🧠 Using sugarless gum or hard candy stimulates salivation, helping relieve oral dryness and discomfort.

🧠 Managing dry mouth is important to reduce the risk of dental caries, oral infections, and difficulty swallowing.

🧠 This education promotes comfort while preventing secondary complications associated with chronic xerostomia.

🧠 ✅ Encourage the client to engage in regular physical activity

🧠 The client has experienced a significant weight gain of 13.7 kg (30.1 lb) in 6 months, a common adverse effect of second-generation antipsychotics, including clozapine.

🧠 Clozapine increases risk for metabolic syndrome, insulin resistance, and type 2 diabetes, which explains the addition of metformin to the regimen.

🧠 Regular physical activity helps manage weight, blood glucose levels, and cardiovascular risk.

🧠 Teaching lifestyle modification is essential to long-term health and medication adherence.

🧠 ✅ Educate client to have neutrophil count drawn every month

🧠 Clozapine carries a serious risk of agranulocytosis, a potentially life-threatening reduction in neutrophils.

🧠 This client’s absolute neutrophil count (ANC) has dropped to 1,500/mm³, which is below the normal reference range and requires close monitoring.

🧠 Monthly ANC monitoring is mandatory to detect early neutropenia and prevent severe infection.

🧠 Education empowers the client to comply with required laboratory monitoring and recognize infection risk.

❌ Topics NOT Appropriate to Include (Elaborated):

❌ Instruct the client to continue taking clozapine

❌ Explanation:

❌ The client presents with fever, sore throat, body aches, and fatigue, which are classic warning signs of clozapine-induced neutropenia or infection.

❌ With a declining ANC and signs of infection, the priority is immediate evaluation, not reassurance to continue the medication.

❌ Nurses should never independently instruct continuation of clozapine when agranulocytosis is suspected.

❌ The provider must evaluate and determine whether the medication should be held or adjusted.

❌ Teach the client about healthy high-calorie snacks

❌ Explanation:

❌ The client already has central abdominal weight gain, indicating increased metabolic risk.

❌ High-calorie snacks—even if “healthy”—would worsen weight gain, insulin resistance, and cardiovascular risk.

❌ Education should instead focus on balanced nutrition, portion control, and weight management.

❌ This teaching contradicts the client’s current clinical needs.

🧠 Blank 1: Lithium toxicity

🧠 This client has just been prescribed lithium 600 mg PO twice daily, and several current findings increase the risk that lithium could accumulate to toxic levels.

🧠 Lithium is handled by the kidneys in a way that closely parallels sodium, so anything that lowers sodium or reduces circulating volume can cause the body to retain lithium.

🧠 The client is showing vomiting, minimal oral intake, and requires prompting to drink—these raise the risk for dehydration and electrolyte imbalance, both of which predispose to lithium toxicity.

🧠 Early signs of lithium-related neurologic effect can include coarse tremor, and this client already has coarse hand tremors noted, which makes close monitoring especially important.

🧠 Blank 2: Sodium level

🧠 The client’s sodium is 132 mEq/L, which is below normal and is a major risk factor for lithium accumulation.

🧠 When sodium is low, the kidneys attempt to conserve sodium by increasing reabsorption in the tubules, and lithium gets reabsorbed along with sodium.

🧠 This increases serum lithium concentration and can push the client from therapeutic levels into toxicity, especially if fluid intake remains poor or vomiting continues.

🧠 For clients taking lithium, maintaining normal hydration and sodium balance is a key safety priority.

❌ Other Options (Elaborated Broadly):

❌ Hypersalivation

❌ Hypersalivation is not supported by the current findings and is not the most critical risk in this scenario.

❌ In fact, lithium is more commonly associated with dry mouth or mild GI effects rather than prominent hypersalivation.

❌ The client’s major current concern is vomiting, low sodium, and poor intake, which point more strongly toward lithium accumulation risk.

❌ There is no documentation of drooling or excessive salivation to make this the best condition.

❌ Fluid volume excess

❌ The client has had poor oral intake, vomiting, and has consumed only 160 mL of water, which does not indicate fluid excess.

❌ Fluid volume excess would present with findings such as edema, crackles, weight gain, and hypertension worsening due to overload, none of which are documented.

❌ The current pattern is more consistent with risk for dehydration, not excess.

❌ Therefore, this is not the most appropriate condition.

❌ Thrombocytopenia

❌ Explanation:

❌ The platelet count is 280,000/mm³, which is within normal range and does not indicate risk for thrombocytopenia at this time.

❌ Thrombocytopenia would be suggested by low platelets, bleeding tendencies, or petechiae—none are present.

❌ The medications ordered (risperidone, lithium, lorazepam) are not primarily linked to acute platelet suppression in the typical clinical scenario.

❌ This is not the priority risk supported by the data.

❌ Hypertensive crisis

❌ Although the client’s blood pressure is elevated (144/96 then 138/94), it is not in the range of a hypertensive crisis (typically ≥180 systolic or ≥120 diastolic).

❌ The readings are more consistent with stress-related elevation during acute mania and hospitalization.

❌ There are no signs of acute target-organ damage (e.g., chest pain, neurologic deficits, pulmonary edema) documented.

❌ This makes hypertensive crisis an unlikely immediate risk compared with lithium-related concerns.

❌ Findings (Why the other “Finding” options are not the best match):

❌ Fluid intake

❌ Low fluid intake is important, but in lithium therapy, the more direct driver of lithium retention shown here is hyponatremia.

❌ Fluid intake contributes to dehydration risk, but the lab-confirmed sodium level provides a clearer mechanism for lithium accumulation.

❌ The best match pairs the condition with the most specific and clinically linked finding.

❌ Therefore, “fluid intake” is less precise than “sodium level” for the blank.

❌ Lorazepam

❌ Lorazepam does not cause lithium toxicity and is prescribed PRN for anxiety/agitation.

❌ Its main concerns include sedation, respiratory depression (at high doses), and falls—not lithium accumulation.

❌ There is no evidence lorazepam is causing the client’s vomiting or electrolyte imbalance.

❌ It does not explain the condition in the stem.

❌ Lithium level (0.6 mEq/L)

❌ The current lithium level is below therapeutic range, so it does not indicate toxicity at this moment.

❌ The question asks what the client is at risk for developing, not what they have now.

❌ Risk is driven by changes that can cause lithium to rise—especially low sodium and dehydration.

❌ Therefore, the lithium level itself is not the key factor creating risk; it is the sodium imbalance and intake issues.

📝 Advance directives are legal documents that allow any competent adult, including those with schizophrenia, to express their wishes regarding future health care.

📝 Clients have the right to appoint a health care surrogate (durable power of attorney for health care) who can make decisions on their behalf if they become unable to do so.

📝 A diagnosis of mental illness does not automatically remove decision-making capacity.

📝 This statement reflects correct understanding of patient autonomy and legal rights.

❌ “Clients will need their provider’s approval before signing advance directives.”

❌ Providers do not approve advance directives; they only verify capacity if questioned.

❌ Requiring provider approval would violate patient autonomy.

❌ “Clients should contact the court if they wish to change their living will.”

❌ Living wills can be changed or revoked by the client at any time, without court involvement.

❌ This statement incorrectly implies a legal barrier.

❌ “Clients must designate a guardian to initiate their advance directives.”

❌ Guardianship is a legal process used only when clients lack capacity.

❌ It is not required to complete advance directives.

🧬 Alpha-fetoprotein (AFP) is a maternal serum marker used to screen for neural tube defects such as spina bifida.

🧬 AFP screening is part of routine prenatal care and is especially relevant when there is a family history of genetic abnormalities.

🧬 Although AFP is measured later in pregnancy, the information about its purpose is accurate and appropriate teaching.

🧬 This statement correctly matches the test with what it detects.

❌ A Coombs test determines cystic fibrosis.

❌ The Coombs test evaluates hemolytic disease, not genetic disorders like cystic fibrosis.

❌ Chorionic villi sampling during week 34.

❌ CVS is performed at 10–13 weeks, not in the third trimester.

❌ Amniotic fluid screening identifies bladder anomalies.

❌ Amniocentesis detects chromosomal and genetic disorders, not specific bladder defects.

🧤 Peripheral neuropathy causes decreased sensation, increasing the risk for burns and injury.

🧤 Wearing gloves protects the hands from temperature extremes, sharp objects, and chemicals.

🧤 This intervention directly addresses safety and injury prevention.

🧤 It is a standard teaching point for neuropathy management.

❌ Wear loose-fitting shoes.

❌ Shoes should be well-fitting, not loose, to prevent falls.

❌ Inspect feet weekly.

❌ Feet should be inspected daily, not weekly.

❌ Eat foods low in fiber.

❌ Fiber intake is unrelated to neuropathy management.

💊 Morphine is an opioid that significantly decreases gastrointestinal motility.

💊 Absent bowel sounds suggest possible paralytic ileus or bowel obstruction, conditions that opioids can worsen.

💊 Administering morphine in this setting increases the risk of severe constipation, abdominal distention, and bowel perforation.

💊 This finding requires withholding the medication and notifying the provider before administration.

❌ Respiratory rate of 14/min

❌ This rate is within normal adult limits and does not indicate respiratory depression.

❌ Morphine is contraindicated when RR is significantly low (e.g., <12/min).

❌ Blood pressure of 100/60 mm Hg

❌ This BP is low–normal but not unstable.

❌ Morphine may cause mild vasodilation, but this value alone is not a contraindication.

❌ Urine output of 100 mL/hr

❌ This indicates adequate renal perfusion.

❌ Good urine output does not prevent morphine use.

✍️ Medication documentation must use clear, approved abbreviations to prevent errors.

✍️ “Subcut” and “every 12 hr” are accepted, unambiguous terms.

✍️ Avoiding unsafe abbreviations reduces the risk of misinterpretation and dosing errors.

✍️ This entry correctly reflects the prescription as written.

❌ Enoxaparin 30 mg SQ q AM and q HS

❌ “SQ,” “qAM,” and “HS” are unsafe abbreviations.

❌ Timing is ambiguous and can lead to administration errors.

❌ Enoxaparin 30 mcg SC q12 hour

❌ Incorrect dose unit (micrograms instead of milligrams).

❌ This represents a serious medication error.

❌ Enoxaparin 30 mg sub q every AM and HS

❌ Uses unsafe timing abbreviations.

❌ Not consistent with “every 12 hours.”